CRNX
Crinetics Pharmaceuticals Inc
Price:  
30.42 
USD
Volume:  
591,222.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRNX WACC - Weighted Average Cost of Capital

The WACC of Crinetics Pharmaceuticals Inc (CRNX) is 7.0%.

The Cost of Equity of Crinetics Pharmaceuticals Inc (CRNX) is 10.25%.
The Cost of Debt of Crinetics Pharmaceuticals Inc (CRNX) is 5.00%.

Range Selected
Cost of equity 7.00% - 13.50% 10.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 8.6% 7.0%
WACC

CRNX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 1.55
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 13.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 8.6%
Selected WACC 7.0%